Avinger Company Overview
About Avinger
Avinger (NASDAQ:AVGR) is a medical device company dedicated to revolutionizing the treatment of vascular diseases through its innovative, image-guided therapy solutions. Avinger's primary focus lies in developing products that integrate optical coherence tomography (OCT) with catheter-based systems, aiming to improve the way physicians diagnose and treat arterial diseases, including peripheral artery disease (PAD). Their flagship products, like the Pantheris Lumivascular atherectomy system, are designed to offer real-time, high-resolution imaging from inside the artery, allowing for precise removal of plaque without damaging the vessel. Avinger's projects are directed towards reducing the burden of vascular disease globally, enhancing patient outcomes, and making the interventional procedures safer and more effective. Their objectives also include continuous innovation, expansion into new markets, and improving the ease of use and efficacy of their technology to meet the needs of healthcare providers and patients worldwide.
Snapshot
Operations
Products and/or services of Avinger
- Pantheris, a lumivascular atherectomy system for treating peripheral artery disease (PAD) through image-guided plaque removal.
- Ocelot, a catheter system employing real-time optical coherence tomography for chronic total occlusion (CTO) navigation.
- Lightbox imaging console supports Pantheris and Ocelot by providing high-resolution, intravascular imaging during interventions.
- TigerTriever, an image-guided CTO recanalization catheter designed for precision and safety in peripheral interventions.
- Wildcat, a catheter designed to navigate highly stenosed arteries and assist in crossing peripheral CTOs.
Avinger executive team
- Mr. Nabeel P. Subainati CPAVP of Finance, Principal Financial Officer & Principal Accounting Officer
- Mr. Philip R. PreussChief Commercial Officer
- Dr. Jaafer Golzar FACC, M.D.Chief Medical Officer